Evidence map›Paper›PMID 36147897›Full record

ArticlePHAGE (New Rochelle, N.Y.)2020

Natural and Induced Antibodies Against Phages in Humans: Induction Kinetics and Immunogenicity for Structural Proteins of PB1-Related Phages.

Katarzyna Hodyra-Stefaniak, Zuzanna Kaźmierczak, Joanna Majewska, Sanna Sillankorva, Paulina Miernikiewicz, Ryszard Międzybrodzki, Andrzej Górski, Joana Azeredo, Rob Lavigne, Dorota Lecion and 6 more

Open access · diamondAbstract read
In one paragraph

Article in PHAGE (New Rochelle, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Immune Responses to Phage Therapy in Humans: A Review.The Journal of infectious diseases · 2026
    Review
  4. Article
  5. Revisiting the Fight AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Article
  8. Phage-induced protection against lethal bacterial reinfection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Katarzyna Hodyra-StefaniakHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Zuzanna KaźmierczakHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Joanna MajewskaHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Sanna SillankorvaInstitute for Biotechnology and Bioengineering-Centre of Biological Engineering, University of Minho, Braga, Portugal.
Paulina MiernikiewiczHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Ryszard MiędzybrodzkiHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Andrzej GórskiHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Joana AzeredoInstitute for Biotechnology and Bioengineering-Centre of Biological Engineering, University of Minho, Braga, Portugal.
Rob LavigneLaboratory of Gene Technology, KU Leuven, Leuven, Belgium.
Dorota LecionHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Sylwia NowakFaculty of Biological Sciences, Wroclaw University, Wroclaw, Poland.
Marek HarhalaHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Patryk WaśkoHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Barbara OwczarekHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Katarzyna GembaraHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Krystyna DąbrowskaHirszfeld Institute of Immunology and Experimental Therapy, Bacteriophage Laboratory, Polish Academy of Sciences, Wroclaw, Poland.
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy · PLInstitute for Biotechnology and Bioengineering · PTInternational Iberian Nanotechnology Laboratory · PTKU Leuven · BEUniversity of Wrocław · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibodiesimmune responsePB1-related phagesphage therapyPseudomonas aeruginosa PAO1virion proteins

Identifiers

PMID36147897
PMCPMC9041471
OpenAlexW3036323846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.